• TMS Machine
  • Course
  • Store
  • Videos
  • Print
  • Login
  • Register
  • Inquire now

This site uses cookies to assist with functionality and analyze your use of our services. Read our Privacy Policy.

Continue
  • TMS Machine
  • Store
  • Other Products
    • CloudEMG
    • Neuronavigation
  • Resources
    • Videos
    • CPT Codes
    • Protocols
    • Print
  • Course
  • Login
  • Contact us

Notice for non FDA cleared protocols

The CloudTMS system manufactured by Neurosoft Ltd is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

Using the CloudTMS system for any indication(s) not currently cleared by the FDA is considered for investigational use only. By clicking agree or by using any techniques outlined in the video and text within, you indicate your agreement with these terms and conditions.

I agree

Testimonials

What our customers are saying about CloudTMS

  • All
  • Conferences
  • Interviews
  • Testimonials
  • Training
1:25

Dr. Rustin Berlow

Dr. Rustin Berlow of the American Brain Stimulation Clinic talks about why he first got interested in transcranial magnetic stimulation therapy and the CloudTMS device.

2:49

Dr. Olga Segal

Dr. Olga Segal of the Segal Psychiatry Network discusses her reasoning for using transcranial magnetic stimulation and shares her greatest success story.

3:01

Bill Shryer of Blackhawk TMS

Bill Shryer of Diablo Behavioral Healthcare and Blackhawk TMS discusses CloudTMS.

Company Home About us Store Contact
CloudTMS TMS Machine CloudTMS+ Membership Extended Warranty
Resources CPT Codes Protocols Videos
Useful links Courses FAQs Partners
Privacy policy Terms & conditions Copyright

Disclaimer: The data generated with the aid of CloudNeuro's devices, software, and services is intended to be an aid to properly trained healthcare professionals. Interpretation of the data, the diagnosis of the medical conditions, and the subsequent development of treatment plans must be performed by and are the sole responsibility of the appropriately trained healthcare professionals. Such interpretations and decisions must be made in the context of other patient specific medical information.